Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, USA.
Department of Psychology, University of California, Los Angeles, USA.
Psychol Med. 2022 Jun;52(8):1517-1526. doi: 10.1017/S0033291720003335. Epub 2020 Sep 28.
Cognitive deficits at the first episode of schizophrenia are predictive of functional outcome. Interventions that improve cognitive functioning early in schizophrenia are critical if we hope to prevent or limit long-term disability in this disorder.
We completed a 12-month randomized controlled trial of cognitive remediation and of long-acting injectable (LAI) risperidone with 60 patients with a recent first episode of schizophrenia. Cognitive remediation involved programs focused on basic cognitive processes as well as more complex, life-like situations. Healthy behavior training of equal treatment time was the comparison group for cognitive remediation, while oral risperidone was the comparator for LAI risperidone in a 2 × 2 design. All patients were provided supported employment/education to encourage return to work or school.
Both antipsychotic medication adherence and cognitive remediation contributed to cognitive improvement. Cognitive remediation was superior to healthy behavior training in the LAI medication condition but not the oral medication condition. Cognitive remediation was also superior when medication adherence and protocol completion were covaried. Both LAI antipsychotic medication and cognitive remediation led to significantly greater improvement in work/school functioning. Effect sizes were larger than in most prior studies of first-episode patients. In addition, cognitive improvement was significantly correlated with work/school functional improvement.
These results indicate that consistent antipsychotic medication adherence and cognitive remediation can significantly improve core cognitive deficits in the initial period of schizophrenia. When combined with supported employment/education, cognitive remediation and LAI antipsychotic medication show separate significant impact on improving work/school functioning.
精神分裂症首次发作时的认知缺陷可预测功能结局。如果我们希望预防或限制该障碍的长期残疾,那么早期改善认知功能的干预措施至关重要。
我们完成了一项针对认知矫正和长效注射(LAI)利培酮的 12 个月随机对照试验,共纳入 60 名近期首发精神分裂症患者。认知矫正包括针对基本认知过程和更复杂的、逼真情境的方案。具有相同治疗时间的健康行为训练是认知矫正的对照组,而在 2×2 设计中,口服利培酮是 LAI 利培酮的对照组。所有患者均提供支持性就业/教育,以鼓励其重返工作或学校。
抗精神病药物治疗依从性和认知矫正均有助于认知改善。在 LAI 药物治疗条件下,认知矫正优于健康行为训练,但在口服药物治疗条件下则不然。当协变量包括药物依从性和方案完成时,认知矫正也更优。LAI 抗精神病药物和认知矫正均导致工作/学校功能显著改善。效果大小大于大多数首次发病患者的先前研究。此外,认知改善与工作/学校功能改善显著相关。
这些结果表明,持续的抗精神病药物治疗依从性和认知矫正可以显著改善精神分裂症初始阶段的核心认知缺陷。当与支持性就业/教育相结合时,认知矫正和 LAI 抗精神病药物单独对改善工作/学校功能具有显著影响。